Clinical trial
ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan…
NCT00140907 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00140907 |
|---|---|
| Title | ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED) |
| Official title | A Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Renal Protective Effects of Losartan in Patients With Renal Transplant |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | High Blood Pressure |
| Intervention type | Drug |
| Interventions | losartan potassium, Comparator: Placebo |
| Enrollment | 367 |
| Start date | Mar 14, 2000 |
| Primary completion | Jan 1, 2005 |
| Completion | Jan 1, 2005 |
| First posted | Sep 1, 2005 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: